000 | 03675namaa22004331i 4500 | ||
---|---|---|---|
003 | OSt | ||
005 | 20250223033206.0 | ||
008 | 231105s2022 ua a|||frm||| 000 0 eng d | ||
040 |
_aEG-GICUC _beng _cEG-GICUC _dEG-GICUC _erda |
||
041 | 0 |
_aeng _beng _bara |
|
049 | _aDeposit | ||
082 | 0 | 4 |
_a615.37 _221 |
092 |
_a615.37 _221 |
||
097 | _aM.Sc | ||
099 | _aCai01.11.07.M.Sc.2022.Na.S | ||
100 | 0 |
_aNada Waheed Ahmed Radwan, _epreparation. |
|
245 | 1 | 0 |
_aSerum soluble interleukin–2 receptor alpha and rantes chemokine as potential biomarkers for Covid–19 infection / _cby Nada Waheed Ahmed Radwan ; Supervised by Prof. Dr. Dalia Ahmed Aly Labib, Prof. Dr. Rasha Mohamad Hosny Shahin. |
246 | 1 | 5 | _aمستوى مستقبلات IL-2 الذائبة و كيموكين RANTES فى الدم كمؤشرات حيوية لعدوى فيروس كورونا المستجد |
264 | 0 | _c2022. | |
300 |
_a102 pages : _bIllustrations ; _c25 cm. + _eCD. |
||
336 |
_2rdacontent _atext |
||
337 |
_2rdamedia _aUnmediated |
||
338 |
_2rdacarrier _avolume |
||
502 | _aThesis (M.Sc.)-Cairo University, 2022. | ||
504 | _aBibliography: pages 88-100. | ||
520 | _aThe COVID 19 Pandemic has been a global emergency caused by the outbreak of SARS-CoV2 virus in Wuhan, Hubei, China in November 2019. The disease is characterized by acute respiratory distress among other symptoms produced by immune system disturbance and cytokine storm. Objective: To determine the serum level of soluble IL-2Ra and RANTES in COVID 19 patients and compare with healthy controls as well as detect correlation with disease severity. Methods: A case-control study was conducted on 60 patients with a positive nasopharyngeal swab tested by RealTime PCR for SARS- CoV2 admitted to isolation wards of Kasr Alainy Hospitals and COVID 19 outpatient clinics, and 25 healthy controls to measure serum levels of soluble IL-2Ra and RANTES using Enzyme Linked Immunosorbent Assay. Results: The results revealed no statistically significant difference in serum levels of soluble IL-2Ra and RANTES between patients and healthy controls, neither was there a difference in serum levels of both parameters between severe and non-severe cases of COVID 19. | ||
520 | _aتحديد مستوى مصل IL-2Ra القابل للذوبان و RANTES في مرضى COVID 19 ومقارنتها مع الضوابط الصحية وكذلك الكشف عن الارتباط مع شدة المرض. الطرق: أجريت دراسة الحالات والشواهد على 60 مريضا يعانون من تم اختبار مسحة البلعوم الأنفي الإيجابية بواسطة RealTime PCR لمرض السارس- تم إدخال CoV2 إلى أجنحة العزل بمستشفيات القصر العيني و عيادات خارجية لكوفيد 19 و25 مراقبة صحية للقياس مستويات مصل IL-2Ra و RANTES القابلة للذوبان باستخدام الإنزيم المرتبط مقايسة الامتصاص المناعي. | ||
530 | _aIssues also as CD. | ||
546 | _aText in English and abstract in Arabic & English. | ||
650 | 0 |
_aSerum _xCOVID-19 |
|
653 | 0 |
_asIL-2Ra _aRANTES _aCOVID 19 |
|
700 | 0 |
_aDalia Ahmed Aly Labib, _ethesis advisor. |
|
700 | 0 |
_aRasha Mohamad Hosny Shahin, _ethesis advisor. |
|
700 | 0 |
_aMohamed Gamal Elansary, _ethesis advisor. |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
900 |
_b01-01-2022 _cDalia Ahmed Aly Labib _cRasha Mohamad Hosny Shahin _cMohamed Gamal Elansary _UCairo University _FFaculty of Medicine _DDepartment of Clinical and Chemical Pathology |
||
905 |
_aHanan _eEssam |
||
942 |
_2ddc _cTH _e21 _n0 |
||
999 |
_c165638 _d165638 |